Artemis Therapeutics Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported net loss was USD 0.035 million compared to USD 0.029 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. For the nine months, net loss was USD 0.119 million compared to USD 0.056 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago.